decisionhealth Newsletters, Part B News - 2001 Issue 10 (October)
CMS Administrator: expect sea change in drug reimbursements
Subscribe or sign in to view the full article.
Article Overview
This article covers a federal policy debate over Medicare drug reimbursement, centered on the average wholesale price approach used for physician-administered drugs. It explains why the issue matters for Medicare payment policy, physician offices, oncology practices, pharmaceutical manufacturers, and congressional oversight, and it summarizes the administration and congressional momentum behind proposed reform.
Why This Topic Matters
Changes to Medicare drug reimbursement can significantly affect payment policy, physician office economics, and broader access and spending debates. The article helps readers understand the policy context and the stakeholders involved in efforts to revise the system.
What You Will Learn
- The policy context surrounding Medicare drug reimbursement
- Why average wholesale price-based payment was being targeted for reform
- Which federal officials and congressional leaders were involved in the debate
- How the issue was framed in relation to patient care and spending priorities
Who Should Read This
- Medical coders
- Billing and reimbursement professionals
- Practice managers
- Healthcare policy analysts
- Oncology billing staff
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com